BR112018015272A2 - uso de inibidores da atividade ou função de pi3k para o tratamento de síndrome de sjögren primária - Google Patents
uso de inibidores da atividade ou função de pi3k para o tratamento de síndrome de sjögren primáriaInfo
- Publication number
- BR112018015272A2 BR112018015272A2 BR112018015272-2A BR112018015272A BR112018015272A2 BR 112018015272 A2 BR112018015272 A2 BR 112018015272A2 BR 112018015272 A BR112018015272 A BR 112018015272A BR 112018015272 A2 BR112018015272 A2 BR 112018015272A2
- Authority
- BR
- Brazil
- Prior art keywords
- syndrome
- treatment
- pi3k activity
- function inhibitors
- primary sjögren
- Prior art date
Links
- 208000034943 Primary Sjögren syndrome Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- MWKYMZXCGYXLPL-ZDUSSCGKSA-N 1-[(3s)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5h-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one Chemical compound C1N(C(=O)CC)CC[C@@H]1NC1=NC=NC2=C1CN(C=1C=C(C(OC)=NC=1)C(F)(F)F)CC2 MWKYMZXCGYXLPL-ZDUSSCGKSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16155123 | 2016-02-10 | ||
| EP16155123.9 | 2016-02-10 | ||
| EP16186188.5 | 2016-08-29 | ||
| EP16186188 | 2016-08-29 | ||
| PCT/IB2017/050743 WO2017118965A1 (en) | 2016-02-10 | 2017-02-10 | Use of inhibitors of the activity or function of pi3k for the treatment of primary sjögren's syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018015272A2 true BR112018015272A2 (pt) | 2018-12-18 |
Family
ID=58016749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018015272-2A BR112018015272A2 (pt) | 2016-02-10 | 2017-02-10 | uso de inibidores da atividade ou função de pi3k para o tratamento de síndrome de sjögren primária |
Country Status (25)
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY158980A (en) | 2008-07-17 | 2016-11-30 | Novartis Ag | Compositions and methods of use for therapeutic antibodies |
| UA112517C2 (uk) | 2010-07-06 | 2016-09-26 | Новартіс Аг | Тетрагідропіридопіримідинові похідні |
| AR083847A1 (es) | 2010-11-15 | 2013-03-27 | Novartis Ag | Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40 |
| MX2013015001A (es) * | 2011-06-27 | 2014-03-31 | Novartis Ag | Formas solidas y sales de derivados de tetrahidro-pirido-pirimidin a. |
| WO2015162584A1 (en) * | 2014-04-24 | 2015-10-29 | Novartis Ag | Crystalline forms of the sulfate salt of n-[5-(3-imidazol-1-yl-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]-acetamide |
-
2017
- 2017-02-10 US US16/075,066 patent/US20190038628A1/en not_active Abandoned
- 2017-02-10 CA CA3011205A patent/CA3011205A1/en active Pending
- 2017-02-10 SI SI201730288T patent/SI3413894T1/sl unknown
- 2017-02-10 EP EP17704548.1A patent/EP3413894B1/en active Active
- 2017-02-10 PT PT177045481T patent/PT3413894T/pt unknown
- 2017-02-10 KR KR1020187022701A patent/KR20180108651A/ko not_active Application Discontinuation
- 2017-02-10 MX MX2018009758A patent/MX2018009758A/es active IP Right Grant
- 2017-02-10 EP EP20162199.2A patent/EP3695840A1/en not_active Withdrawn
- 2017-02-10 WO PCT/IB2017/050743 patent/WO2017118965A1/en active Application Filing
- 2017-02-10 JP JP2018542236A patent/JP7132123B2/ja active Active
- 2017-02-10 DK DK17704548.1T patent/DK3413894T3/da active
- 2017-02-10 ES ES17704548T patent/ES2797091T3/es active Active
- 2017-02-10 LT LTEP17704548.1T patent/LT3413894T/lt unknown
- 2017-02-10 RS RS20200668A patent/RS60477B1/sr unknown
- 2017-02-10 BR BR112018015272-2A patent/BR112018015272A2/pt not_active Application Discontinuation
- 2017-02-10 AU AU2017204936A patent/AU2017204936B2/en active Active
- 2017-02-10 RU RU2018132042A patent/RU2749731C2/ru active
- 2017-02-10 PL PL17704548T patent/PL3413894T3/pl unknown
- 2017-02-10 HU HUE17704548A patent/HUE050632T2/hu unknown
- 2017-02-10 CN CN201780010050.XA patent/CN108601786B/zh active Active
-
2018
- 2018-06-26 IL IL260274A patent/IL260274A/en unknown
- 2018-07-10 CL CL2018001871A patent/CL2018001871A1/es unknown
- 2018-07-11 PH PH12018501490A patent/PH12018501490A1/en unknown
- 2018-12-21 HK HK18116434.0A patent/HK1257288A1/zh unknown
-
2020
- 2020-06-08 HR HRP20200916TT patent/HRP20200916T1/hr unknown
- 2020-06-10 CY CY20201100526T patent/CY1122989T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3413894A1 (en) | 2018-12-19 |
| EP3413894B1 (en) | 2020-03-11 |
| HUE050632T2 (hu) | 2020-12-28 |
| RU2749731C2 (ru) | 2021-06-16 |
| CN108601786A (zh) | 2018-09-28 |
| MX2018009758A (es) | 2018-09-11 |
| JP2019508413A (ja) | 2019-03-28 |
| SI3413894T1 (sl) | 2020-09-30 |
| WO2017118965A1 (en) | 2017-07-13 |
| RS60477B1 (sr) | 2020-08-31 |
| CN108601786B (zh) | 2021-11-02 |
| HK1257288A1 (zh) | 2019-10-18 |
| PL3413894T3 (pl) | 2020-10-05 |
| HRP20200916T1 (hr) | 2020-09-18 |
| KR20180108651A (ko) | 2018-10-04 |
| CL2018001871A1 (es) | 2018-11-23 |
| LT3413894T (lt) | 2020-07-10 |
| RU2018132042A3 (US20030204162A1-20031030-M00001.png) | 2020-05-15 |
| CY1122989T1 (el) | 2021-10-29 |
| US20190038628A1 (en) | 2019-02-07 |
| EP3695840A1 (en) | 2020-08-19 |
| AU2017204936A1 (en) | 2018-07-19 |
| DK3413894T3 (da) | 2020-06-15 |
| IL260274A (en) | 2018-07-31 |
| RU2018132042A (ru) | 2020-03-10 |
| PH12018501490A1 (en) | 2019-03-25 |
| PT3413894T (pt) | 2020-06-16 |
| JP7132123B2 (ja) | 2022-09-06 |
| ES2797091T3 (es) | 2020-12-01 |
| AU2017204936B2 (en) | 2019-06-27 |
| CA3011205A1 (en) | 2017-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015020941A2 (pt) | uso de derivados de pirazolopirimidina para o tratamento de distúrbios relacionados a pi3kdelta | |
| CL2019000941A1 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret. | |
| BR112017007662A8 (pt) | Composto, composição farmacêutica e uso de um composto | |
| CL2013002177A1 (es) | Compuestos derivados de 9h-purinas y 7h-pirrolo[2,3-d]-pirimidinas sustituidas, inhibidores de la pi3k de clase i y/o mtor; su composicon farmaceutica; su combinacion farmaceutica; y su uso en el tratamiento o la prevencion del cancer o trastornos neurodegenerativos. | |
| AR084551A1 (es) | COMPUESTO DE IMIDAZO[4,5-C]QUINOLIN-2-ONA COMO INHIBIDOR DUAL DE mTOR/CINASA PI3 | |
| BR112015010663A8 (pt) | formas de dosagem oral de liberação sustentada, e uso de ruxolitinib ou de sal farmaceuticamente aceitável do mesmo | |
| GB201205669D0 (en) | Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof | |
| CL2014001529A1 (es) | Compuestos pirazolo[1,5-a]piridina suistituidos, inhibidores del receptor de tropomiosina quinasa (trk); composicion farmaceutica que los comprende; metodo de inhibicion del recetor de tropomiosina quinasa a (trka); y metodo de tratamiento o prevencion del dolor, cancer, restenosis y aterosclerosis, entre otras enfermedades. | |
| EA201490194A1 (ru) | Комбинированная терапия, включающая ингибитор cdk4/6 и ингибитор pi3k для применения в лечении рака | |
| CL2016000241A1 (es) | Formulación de inhibidores de la syk. | |
| BR112015028501A2 (pt) | derivados de bipirazol como inibidores de jak | |
| MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
| BR112016015057A2 (pt) | Compostos e composições farmacêuticas e respectivos usos | |
| BR112017005314A2 (pt) | inibidores de ssao derivados de imidazo[4,5-c]piridina | |
| CY1124832T1 (el) | 7-βενζυλο-4-(2-μεθυλοβενζυλο)-2,4,6,7,8,9-εξαϋδροϊμιδαζο[1,2-α]πυριδο[3,4-ε]πυριμιδιν-5(1 η)-ονη, τα αλατα της και οι μεθοδοι χρησης τους σε συνδυαστικη θεραπεια | |
| NZ736055A (en) | Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators | |
| MX2016009251A (es) | Derivados de 7-oxo-1, 6-diazabiciclo [3.2.1] octano y su uso como agentes antibacterianos. | |
| MY177365A (en) | Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain | |
| MX2019013198A (es) | Composicion farmaceutica que comprende un inhibidor de (s)-7-(2metoxi-3,5-dimetilpiridin-4-il)-1-(tetrahidrofuran-3-il)- 1h-pirazolo[4,3-c]quinolin-4(5h)-ona (pde9). | |
| MX2015013155A (es) | Formulaciones farmaceuticas de la familia de la tetrandrina y metodo. | |
| CO2018002204A2 (es) | Agentes antibacteriales que comprenden un pirazino [2,3-b]- [1,4] oxazin-3-ona o un sistema de anillo relacionado | |
| BR112017024719A2 (pt) | compostos de hidroxil purina e seu uso | |
| BR112015023078A2 (pt) | inibidores de pirrolopirimindina cdk9 quinase | |
| BR112018015272A2 (pt) | uso de inibidores da atividade ou função de pi3k para o tratamento de síndrome de sjögren primária | |
| BR112015025033A2 (pt) | prodrogas de inibidores da pde-5 do tipo pirimidina bicíclico substituídas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI N? 10196/2001, QUE MODIFICOU A LEI N? 9279/96, A CONCESS?O DA PATENTE EST? CONDICIONADA ? ANU?NCIA PR?VIA DA ANVISA. CONSIDERANDO A APROVA??O DOS TERMOS DO PARECER N? 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL N? 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVID?NCIAS CAB?VEIS. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2631 DE 08/06/2021 POR TER SIDO INDEVIDA. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |